Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07343661Phase 4Enrolling By Invitation

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

Role: lead

NCT07268833Recruiting

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

Role: collaborator

NCT05320250Completed

Saliva and Extracellular Vesicles for Parkinson's Disease

Role: collaborator

NCT06495762Not Yet Recruiting

Preventing Premature Family Maladjustment: an e-Health Interdisciplinary Research

Role: collaborator

NCT06109506Unknown

Towards a Tailored Approach for Patients With Acute Diverticulitis and Abscess Formation. A Multicenter Cohort Analysis

Role: collaborator

NCT05659407Unknown

BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis

Role: collaborator

NCT04327323Unknown

CCM Italian Registry

Role: collaborator

NCT04166968Not ApplicableUnknown

Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery

Role: collaborator

NCT03313154Completed

Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

Role: lead

NCT02341066Unknown

Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study)

Role: collaborator

All 10 trials loaded